Skip to content
healthcare.dev
Get a free key

RANOLAZINE

NDC 73141-022, RANOLAZINE, tablet, film coated, extended release, from A2A Integrated Pharmaceuticals.

Product NDC
73141-022
Status
Listed
Labeler
A2A Integrated Pharmaceuticals
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213517
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73141-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE1000 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
73141-022-027314100220260 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73141-022-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9fb62878-c76a-4be2-99be-962ce2956af2

Use it

Look up 73141-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73141-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73141-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.